• FOUNDED 2021


The COSA Global Oncology Group was established in response to rising cancer incidence globally with 70% of new diagnoses expected to occur in low and middle income countries (LMICs), with a corresponding need for access to cancer prevention, screening, diagnosis and treatment.

This Group aims to promote global oncology in the Asia Pacific region with stakeholders in Australia and New Zealand through these themes:


  • Increase educational partnerships within the APAC region through in-country training, twinning partnerships and observerships
  • Engage and train ANZ clinicians in global oncology


  • Increase research capacity in LMICs through regional collaboration
  • Promote high quality research in global oncology within ANZ


  • Leverage funding from professional institutions, government, industry, not-for-profit organisations and hospitals
  • Engage members in global cancer policy and advocacy


  • Support and promote institutional collaborations between ANZ and APAC LMICs through partnerships between clinical and research institutions
  • Foster collaboration in global cancer care among COSA members (See here for a recent example)
  • Collaboration in grant applications for global oncology projects
  • Working with international partners who have members active in this area


Group information

[Chair] Prof Desmond Yip, The Canberra Hospital, ACT

[Deputy Chair] Dr Milita Zaheed, Prince of Wales Hospital, NSW

Dr Madhavi Chilkuri, Ballarat Austin Radiation Oncology Centre, VIC

Prof Christos Karapetis, Flinders Medical Centre, SA

Ms Karen Lanyon, Consumer

Prof Sankha Mitra, Kalgoorlie Health, WA

Dr Brooke Wilson, Queen’s University, Kingston, Canada 

Dr Ganes Pranavan, The Canberra Hospital, ACT

Mrs Marissa Ryan, Princess Alexandra Hospital, QLD

Dr Mei Ling Yap, Liverpool and Macarthur Cancer Therapy Centres, NSW

What’s the latest

Group Chair

Group Chair Image
Group Chair

Desmond Yip

Global Oncology Group Chair